Governance of Personality-Modifying Biotech Interventions

1. Introduction

Personality-modifying biotechnology refers to biological, pharmaceutical, genetic, or neurotechnological interventions that may produce substantial changes in an individual's personality traits, emotional responses, motivation, memory, impulse control, preferences, or patterns of behaviour.

Examples include:

Psychiatric medicines that influence mood, emotional regulation, or motivation.

Deep brain stimulation (DBS) that may produce changes in behaviour, impulse control, or a person's sense of identity.

Experimental interventions affecting neural circuits associated with emotion, memory, or decision-making.

Genetic or cellular interventions investigated for their possible effects on neurological and behavioural functions.

Emerging neurotechnologies intended to modify cognitive or emotional processes.

Not every treatment that changes mood or behaviour constitutes personality modification in a legally significant sense. The relevant issue is whether an intervention has foreseeable or actual effects on a person's mental functioning, autonomy, identity, or capacity to make decisions.

Research on deep brain stimulation has documented ethical concerns where behavioural changes affect a patient's decision-making capacity or raise questions about psychological continuity.

PMC

+1

The central governance question is: How can the law permit beneficial medical treatment and legitimate scientific research while protecting individuals against coercive, deceptive, unsafe, or non-consensual modification of their mental and behavioural characteristics?

There is no single comprehensive statute devoted exclusively to personality-modifying biotechnology. Its governance depends on the intervention involved and the applicable rules on medical treatment, clinical research, pharmaceuticals, mental healthcare, human rights, privacy, and professional responsibility.

2. Meaning and Scope of Governance

Governance means the combination of legislation, regulatory approvals, institutional review, professional standards, ethical safeguards, judicial oversight, and remedies that control the development and use of personality-modifying interventions.

Its principal objectives are:

Protection of autonomy: Individuals should ordinarily decide whether to undergo interventions affecting their mental functioning.

Informed consent: Patients and research participants must understand material risks, possible behavioural changes, uncertainties, and alternatives.

Protection of psychological integrity: Interventions should not subject people to unjustified interference with their mental processes or personal identity.

Clinical safety: Benefits and risks should be assessed using appropriate scientific evidence.

Freedom from coercion: Employers, public authorities, institutions, caregivers, and researchers should not improperly compel personality modification.

Accountability: Providers and researchers should be answerable for negligent treatment, unlawful experimentation, deceptive claims, and violations of applicable safeguards.

These objectives apply differently to clinical treatment, experimental research, voluntary enhancement, and interventions imposed in custodial or institutional settings.

3. Constitutional and Human Rights Principles

A. Right to life, liberty, and dignity

In India, Article 21 of the Constitution protects life and personal liberty. Its interpretation encompasses dignity, bodily integrity, and decisional autonomy.

Personality-modifying interventions may engage these protections when they substantially affect a person's mental functioning, decision-making, or freedom to determine the course of their own life.

Article 14, which guarantees equality before the law, may also become relevant when interventions are imposed discriminatorily or when regulatory decisions are arbitrary. Article 19 may be implicated in particular circumstances involving freedom of expression or other protected freedoms.

Governance implication: Public authorities must have a lawful basis for compulsory interventions and must respect applicable constitutional safeguards. Private healthcare providers are also subject to relevant statutory, professional, contractual, and civil obligations.

B. Mental privacy and psychological integrity

Mental privacy concerns the protection of a person's inner life, thoughts, emotions, and sensitive psychological information.

Psychological integrity concerns protection against unjustified interference with mental functioning and the individual's ability to maintain a meaningful relationship with their own identity.

These concepts are particularly important when biotechnology may alter emotional responses, impulse control, memory, or decision-making. However, the precise scope of a freestanding legal right to psychological continuity or cognitive liberty remains unsettled in many jurisdictions.

In India, the constitutional right to privacy recognised in Justice K.S. Puttaswamy (Retd.) v. Union of India provides an important legal foundation for analysing such interventions.

C. Freedom of thought and protection against coercion

Article 18 of the International Covenant on Civil and Political Rights (ICCPR) protects freedom of thought, conscience, and religion. Article 17 protects against arbitrary or unlawful interference with privacy, while Article 7 prohibits torture and cruel, inhuman, or degrading treatment.

These provisions may be relevant where interventions are imposed to change a person's beliefs, emotional dispositions, or behaviour. Their application depends on the nature of the intervention and the relevant legal obligations.

Not every treatment that influences mental states violates freedom of thought. Legitimate treatment may appropriately alter symptoms or behaviour when undertaken under applicable legal and ethical safeguards.

4. Indian Statutory Framework

A. Mental Healthcare Act, 2017

The Mental Healthcare Act, 2017 is particularly important for interventions undertaken as part of mental healthcare in India.

Relevant provisions include:

Section 4: Capacity to make mental healthcare and treatment decisions.

Sections 5–13: Advance directives and related safeguards.

Sections 18–28: Rights of persons with mental illness, including access to care, information, confidentiality, and complaints.

Section 22: Right to information concerning mental healthcare and treatment.

Section 25: Right to access medical records.

Section 94: Emergency treatment, subject to the statutory conditions and restrictions.

The Act defines informed consent in section 2(i) as consent to a specific intervention given without force, undue influence, fraud, threat, mistake, or misrepresentation and after disclosure of adequate information, including risks, benefits, and alternatives, in a language and manner understood by the individual. <Cite refs={["turn222917search48","turn222917search50"]}/>

These protections are relevant when treatment may produce significant behavioural or emotional changes. A clinician should explain material risks and alternatives rather than treating consent to general psychiatric care as unlimited permission for every intervention.

The Act does not independently regulate every form of biotechnology or establish a separate licensing regime for personality modification.

B. Drugs and Cosmetics Act, 1940, and applicable clinical-trial rules

Pharmaceutical interventions affecting mood, cognition, or behaviour may be governed by the Drugs and Cosmetics Act, 1940, and the New Drugs and Clinical Trials Rules, 2019, where applicable.

Relevant regulatory issues include:

Authorisation and oversight of clinical trials.

Safety and efficacy evidence.

Ethical review and informed consent.

Reporting of adverse events.

Protection of research participants.

Compliance with applicable requirements for new drugs and investigational products.

An intervention marketed as personality enhancement cannot avoid pharmaceutical regulation merely by being described as a lifestyle or behavioural product. Its regulatory classification depends on its composition, intended use, claims, and applicable law.

C. Indian Council of Medical Research ethical guidance

The Indian Council of Medical Research (ICMR) National Ethical Guidelines for Biomedical and Health Research Involving Human Participants provide an important ethical framework for human research.

Research capable of affecting personality, cognition, or emotional regulation should receive appropriate ethical review. The review should consider scientific validity, risk minimisation, participant selection, consent, privacy, and arrangements for responding to adverse outcomes.

Where the intervention is subject to statutory clinical-trial requirements, ethical guidance supplements rather than replaces those requirements.

D. Digital Personal Data Protection Act, 2023

Personality-modifying interventions may generate sensitive information about emotional responses, neurological functioning, medication use, or behavioural patterns.

India's Digital Personal Data Protection Act, 2023 may apply to the processing of digital personal data, subject to its provisions, commencement, and applicable rules. Its scope and obligations should be assessed against the law in force at the relevant time.

The governance framework should also account for applicable medical confidentiality obligations and any other relevant data-protection rules. Information about a person's mental functioning should not be collected, disclosed, or reused beyond lawful and appropriately justified purposes.

5. Important Case Laws

The following cases provide important principles for evaluating personality-modifying interventions. Most are analogous authorities concerning consent, autonomy, privacy, or compulsory medical treatment; they did not directly adjudicate modern personality-modifying biotechnology.

Case 1: Samira Kohli v. Dr. Prabha Manchanda, (2008) 2 SCC 1

Court: Supreme Court of India.

Facts: The dispute concerned a diagnostic procedure that was extended to include a surgical intervention without the patient's specific consent.

Legal principle: The Supreme Court explained the requirements of valid medical consent. Consent must be voluntary and relate to the particular treatment proposed. In an ordinary non-emergency situation, a doctor cannot treat consent to one procedure as blanket authority for a materially different procedure.

Application: Consent to a neurological or psychiatric intervention should not automatically be interpreted as consent to additional interventions that carry materially different risks of behavioural or psychological change.

Researchers and clinicians should explain the nature of the intervention, material risks, likely benefits, and reasonable alternatives.

Significance: This is a leading Indian authority on informed consent and patient autonomy. <Cite refs={["turn222917search0","turn496371search7"]}/>

Case 2: Justice K.S. Puttaswamy (Retd.) v. Union of India, (2017) 10 SCC 1

Court: Supreme Court of India, nine-judge Constitution Bench.

Facts: The Court considered whether privacy is a constitutionally protected fundamental right.

Legal principle: The Court recognised privacy as an intrinsic part of life and personal liberty under Article 21 and as part of the freedoms guaranteed by Part III of the Constitution.

The judgment connected privacy with dignity, autonomy, and the ability to make personal decisions. Restrictions on privacy must satisfy applicable requirements of legality, legitimate purpose, and proportionality.

Application: Compulsory personality modification by public authorities, unjustified collection of psychological information, or state-sponsored interventions that interfere with mental autonomy may raise constitutional questions.

A regulatory scheme would need to establish a lawful basis and justify the interference under the applicable constitutional standards.

Significance: This judgment provides a foundational constitutional framework for protecting personal autonomy against unjustified interference. <Cite refs={["turn222917search1","turn222917search4"]}/>

Case 3: Suchita Srivastava v. Chandigarh Administration, (2009) 9 SCC 1

Court: Supreme Court of India.

Facts: The case concerned the reproductive autonomy of a woman with an intellectual disability and whether a pregnancy could be terminated without her consent.

Legal principle: The Supreme Court recognised reproductive choice as an aspect of personal liberty and bodily autonomy under Article 21. Disability does not, by itself, eliminate an individual's right to make decisions.

Application: A person's diagnosis or disability should not automatically justify imposing an intervention intended to alter their personality or behaviour. Decision-making capacity must be evaluated under the applicable legal framework, rather than presumed absent because an individual has a particular diagnosis.

Where supported decision-making or statutory safeguards apply, they should be used appropriately.

Significance: The case supports autonomy and dignity in medical decision-making. Its application to personality-modifying biotechnology is analogical rather than direct.

Case 4: Sharda v. Dharmpal, (2003) 4 SCC 493

Court: Supreme Court of India.

Facts: The case arose from matrimonial proceedings involving an application for medical examination.

Legal principle: The Supreme Court considered the circumstances in which a court may order a medical examination in legal proceedings. The judgment did not establish an unlimited power to compel medical intervention; such orders must be evaluated under the relevant legal framework and safeguards.

Application: The case is relevant when considering whether an individual may be compelled to undergo psychiatric, neurological, or other examinations in legal proceedings. It does not authorise compulsory personality modification.

Any proposed intervention must be distinguished from an examination, and its legality must be independently established.

Significance: This case illustrates the need to balance personal integrity with legitimate judicial purposes.

Case 5: Common Cause v. Union of India, (2018) 5 SCC 1

Court: Supreme Court of India, Constitution Bench.

Facts: The case concerned dignity, autonomy, and the legal status of advance medical directives and decisions relating to end-of-life care.

Legal principle: The Court recognised the importance of autonomy and dignity in medical decision-making, including the ability to express treatment preferences in advance under the applicable safeguards.

Application: Personality-modifying interventions may have effects that a person would not wish to accept if particular adverse outcomes occurred. Advance care planning, where legally appropriate, can help document treatment preferences and guide later decisions.

However, an advance directive should be applied according to the governing law and its scope; it is not a general authorisation for every future intervention.

Significance: The case reinforces the importance of dignity, autonomy, and advance medical decision-making.

Case 6: Vellore Citizens' Welfare Forum v. Union of India, (1996) 5 SCC 647

Court: Supreme Court of India.

Facts: The litigation concerned industrial pollution and environmental harm.

Legal principle: The Supreme Court recognised the precautionary principle and polluter-pays principle as important components of Indian environmental law.

Application: The case is relevant where a personality-modifying intervention has uncertain but potentially serious risks to individuals or the environment. It supports a preventive approach to scientific risk, although its direct subject was environmental pollution.

In a clinical setting, the corresponding practical lesson is that serious foreseeable risks should be assessed before an intervention is introduced, rather than ignored until harm occurs.

Significance: This is an analogous authority on precaution and the management of uncertainty, not a direct ruling on medical personality modification.

Case 7: Pretty v. United Kingdom, Application No. 2346/02, European Court of Human Rights (2002)

Court: European Court of Human Rights.

Facts: The case concerned a woman with a degenerative disease who sought protection for her decision concerning assisted dying.

Legal principle: In discussing Article 8 of the European Convention on Human Rights, the Court recognised that imposing medical treatment on a mentally competent adult without consent can interfere with physical integrity and private life.

The case did not establish an unrestricted right to every requested medical intervention; it addressed the particular rights and legal questions before the Court.

Application: An intervention intended to alter personality should ordinarily respect the informed choice of a competent adult. Therapeutic benefit alone does not automatically justify overriding refusal.

Significance: This is persuasive comparative authority on autonomy and medical consent, rather than binding Indian precedent. <Cite refs={["turn222917search6","turn496371search5"]}/>

Case 8: Glass v. United Kingdom, Application No. 61827/00, European Court of Human Rights (2004)

Court: European Court of Human Rights.

Facts: The case involved medical treatment administered to a child with severe disabilities despite a serious dispute between the medical team and the child's mother.

Legal principle: The Court found a violation of Article 8 in the circumstances, emphasising the importance of respect for private and family life and the legal safeguards surrounding disputed medical decisions.

Application: Where a proposed personality-modifying intervention involves a minor or a person who cannot independently make the relevant decision, the applicable consent framework, the person's interests and views, and available legal safeguards must be carefully considered.

Parental or institutional preference should not automatically displace the legal rights of the individual concerned.

Significance: This is an analogous human-rights authority on medical decision-making and procedural safeguards. It is not a direct precedent concerning personality-modifying biotechnology.

6. Core Governance Challenges

A. Defining personality change

Personality is complex, context-dependent, and difficult to measure. A change in mood, motivation, or behaviour may represent a desired therapeutic effect, an adverse effect, or an ordinary response to life circumstances.

Regulators should therefore distinguish clinically meaningful changes from minor or temporary effects. Assessment should not assume that every departure from a person's previous behaviour is harmful.

B. Informed consent and decision-making capacity

A central difficulty arises when an intervention itself may affect the individual's capacity to understand information, weigh alternatives, or communicate a decision.

Consent should be obtained before intervention whenever required and should address foreseeable effects on cognition, emotion, impulse control, and behaviour.

For higher-risk research, appropriate safeguards may include repeated capacity assessments, independent counselling, clear withdrawal procedures, and a plan for managing adverse psychological effects.

C. Minors and individuals requiring decision-making support

Children and adults who need decision-making support may be especially vulnerable to interventions motivated by the preferences of caregivers, institutions, or third parties.

Governance should protect the individual's welfare, dignity, and participation in decisions to the extent possible under the law. A disability or diagnosis should not automatically be treated as proof of incapacity.

D. Compulsory treatment and institutional power

Personality-modifying interventions raise particular concerns in prisons, psychiatric facilities, schools, workplaces, and military institutions.

Consent may not be genuinely voluntary where refusal could lead to punishment, loss of employment, reduced privileges, or other serious disadvantages.

Any compulsory intervention must have a valid legal basis and satisfy the safeguards applicable to the setting. Institutional convenience, conformity, or the desire to make a person more compliant should not be treated as sufficient justification by themselves.

E. Uncertain long-term effects

Interventions affecting neural or biological systems may produce effects that are not fully understood at the time of treatment.

Governance should require evidence proportionate to the intervention's risk, appropriate follow-up, adverse-event reporting, and a means of reviewing or modifying treatment when clinically indicated.

F. Data privacy and discrimination

Information about a person's emotional state, neurological characteristics, or treatment history could be misused in employment, insurance, education, or other decisions.

Legal and ethical safeguards should limit unnecessary collection and disclosure, prevent discriminatory use, and protect confidentiality in accordance with applicable law.

7. Recommended Governance Model

A proportionate governance model should include the following safeguards.

These safeguards should be adapted to the intervention's invasiveness, reversibility, intended purpose, evidence base, and potential impact on the individual's autonomy.

8. Legal Consequences of Unlawful Personality Modification

Depending on the facts and the applicable law, unlawful or negligent interventions may result in:

Civil liability for negligence, lack of valid consent, or other actionable wrongs.

Professional disciplinary proceedings against healthcare practitioners.

Regulatory action concerning unlawful clinical research or pharmaceutical use.

Constitutional or public-law remedies where state action violates fundamental rights.

Criminal liability where the conduct satisfies the elements of an applicable offence.

Data-protection remedies or penalties for unlawful processing of personal data, where applicable.

The legal outcome depends on the intervention, the evidence of harm, the consent process, the identity of the responsible actor, and the statutory framework. A personality change alone does not automatically establish negligence or unlawful conduct.

9. Conclusion

Governance of personality-modifying biotechnology lies at the intersection of medical law, constitutional liberty, research ethics, mental healthcare, and human rights.

Indian law already provides important safeguards through Article 21 of the Constitution, the Mental Healthcare Act, 2017, applicable pharmaceutical and clinical-trial rules, and established principles of informed consent. The judgments in Samira Kohli, Puttaswamy, Suchita Srivastava, and Common Cause provide significant guidance on autonomy, dignity, privacy, and medical decision-making.

However, these authorities do not constitute a comprehensive legal code specifically governing biotechnology intended to modify personality. New interventions may require more detailed standards for assessing psychological effects, ensuring ongoing consent, monitoring adverse outcomes, and preventing coercive use.

The governing principle should be that scientific or therapeutic benefit does not, by itself, eliminate an individual's right to dignity, autonomy, and lawful protection against unjustified interference with mental and bodily integrity.